Comment from Advancing New Standards in Reproductive Health at the University of California San Francisco

Summary: Advancing New Standards in Reproductive Health (ANSIRH), a research program based at the University of California San Francisco, supports the citizen petitions to remove the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. They argue that extensive research demonstrates medication abortion is safe and effective, and that current REMS requirements unnecessarily restrict access to care without improving safety outcomes.